Project Snow White: In­ter­nal probe re­veals for­mer MiMedx C-suite spied on em­ploy­ees, lied to reg­u­la­tors and mis­led in­vestors

A 15-month long sweep­ing in­ter­nal in­ves­ti­ga­tion, en­com­pass­ing more than a mil­lion doc­u­ments, thou­sands of hours of se­cret video sur­veil­lance and over 80 wit­ness­es, has brought to light the scan­dalous past of wound care com­pa­ny MiMedx.

The com­pa­ny, which has long been crit­i­cized for its busi­ness prac­tices, sells in­jectable treat­ments — de­rived from the am­ni­ot­ic tis­sue — to treat burns and soft tis­sue wounds, and counts vet­er­ans and mil­i­tary hos­pi­tals as its cus­tomers. MiMedx has al­so faced the ire of FDA, which has pre­vi­ous­ly ac­cused it of fla­grant  man­u­fac­tur­ing vi­o­la­tions and in­di­cat­ed MiMedx’s suite of prod­ucts does not meet its reg­u­la­to­ry stan­dards.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.